Altus Biologics

06/23/2026

Hydration is one of those simple daily habits that can make a real difference in supporting overall wellness. 💧

For individuals living with chronic conditions or receiving biologic therapies, staying hydrated can help support the body’s everyday functions, from energy and circulation to temperature regulation between care visits.

In honor of National Hydration Day, we’re sharing a few easy ways to make hydration feel more manageable throughout the day.

Watch the video for two simple tips to help you stay hydrated.👆

06/21/2026

Today, Altus Biologics celebrates all fathers and father-figures whose care and guidance make a lasting difference. 💙

We’re especially grateful for the fathers across our team. The patience, compassion, and responsibility that shape their role as caregivers at home are also reflected in the way they support patients, providers, and one another.

To every dad, grandfather, mentor, and father-figure in our community: thank you for the care you give, the example you set, and the many ways you show up for those who count on you.

Happy Father’s Day from Altus Biologics. 👔

06/19/2026

Summer schedule 🗓️ changes can make biologic therapy coordination more complex for specialty practices, increasing the risk of missed appointments, delayed infusions, treatment interruptions, and added administrative strain.

For practices offering in-office biologic therapies, proactive planning can help reduce avoidable care gaps and support more stable workflows throughout the summer months. This includes:

📅 Early patient outreach
🔔 Consistent appointment reminders
✅ Timely benefits verification
💊 Coordinated medication management
Together, these strategies can help reduce avoidable care gaps and support more stable workflows throughout the summer months.

Altus Biologics helps specialty practices maintain continuity of care with biologics management support designed to improve scheduling coordination, patient communication, authorization workflows, and operational efficiency.

Read more:

Reducing Summer Care Gaps: Biologic Scheduling Strategies for Specialty Practices. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

06/19/2026

The “MS hug” is a common MS symptom that can feel like a tight band squeezing around the torso.

06/16/2026

Lifestyle habits like nutrition, exercise, smoking cessation, and mental health support can help improve overall wellness and manage rheumatoid arthritis.

06/15/2026

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis.

1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural joint damage in adults with active psoriatic arthritis. 2. Phase 3b APEX data showed stronger clinical responses and less radiographic progression with guselkumab compared wit...

06/11/2026

If you are receiving biologic therapy 🧪 for a chronic condition such as asthma, rheumatoid arthritis, Crohn’s disease, lupus, or psoriasis, planning ahead may help you stay on track with treatment while ☀️ traveling this summer.

➡️ Read more:

Summer Travel and Biologic Therapy: What Patients Should Know Before You Go. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

06/10/2026

Depending on your lupus symptoms and job demands, workplace adjustments may help you stay in your current career.

06/09/2026

📞 Today is National Call Your Doctor Day — a reminder to prioritize the appointments, screenings, and conversations that support long-term health.

📋 For patients managing chronic conditions or receiving biologic therapies, regular check-ins with a healthcare provider can help monitor symptoms, evaluate treatment progress, and identify changes early.

At Altus Biologics, we believe ongoing care starts with consistent support and communication. Today is a great time to ⏰ schedule the appointment, ask the question, or reconnect with your care team about your next step.

06/08/2026

FDA Approves First Golimumab Biosimilars to Treat Rheumatoid Arthritis and Ulcerative Colitis.

The biosimilar approvals do not include Simponi and Simponi Aria’s indications outside of rheumatoid arthritis and ulcerative colitis.